HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N A Darmani Selected Research

MRS 1845

1/2021The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (Cryptotis parva).
1/2019Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N A Darmani Research Topics

Disease

8Vomiting
01/2021 - 02/2001
2Neoplasms (Cancer)
01/2020 - 02/2001
1Pain (Aches)
01/2021
1Cognitive Dysfunction
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Heart Failure
01/2021
1Inflammation (Inflammations)
01/2020
1Hemolysis
12/2001
1Nausea
10/2001
1Tourette Syndrome (Tourette's Syndrome)
10/2001

Drug/Important Bio-Agent (IBA)

6AntiemeticsIBA
01/2021 - 02/2001
4EmeticsIBA
01/2021 - 02/2001
4RimonabantIBA
07/2003 - 02/2001
4CannabinoidsIBA
07/2003 - 02/2001
3Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 07/2003
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2001
3Dronabinol (THC)FDA LinkGeneric
10/2001 - 02/2001
2U 0126 (UO 126)IBA
01/2021 - 01/2019
2netupitantIBA
01/2021 - 01/2019
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 07/2003
2Nifedipine (Adalat)FDA LinkGeneric
01/2021 - 01/2019
2MRS 1845IBA
01/2021 - 01/2019
2nabilone (Cesamet)FDA Link
10/2001 - 02/2001
2Cannabinoid Receptor AgonistsIBA
10/2001 - 02/2001
1Z944IBA
01/2021
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2021
1ICI D2788IBA
01/2021
1Tryptophan HydroxylaseIBA
01/2021
1resiniferatoxinIBA
01/2021
1Palonosetron (Aloxi)FDA Link
01/2021
1Dantrolene (Dantrium)FDA LinkGeneric
01/2021
1Glycogen Synthase Kinase 3IBA
01/2020
1SB 216763IBA
01/2020
1N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA
01/2020
1Substance PIBA
01/2019
1Inositol (Myoinositol)IBA
01/2019
14- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
1bisindolylmaleimide IIBA
01/2019
1GR 73632IBA
01/2019
1Phosphorus (Red Phosphorus)IBA
12/2001
1Fomepizole (Antizol)FDA LinkGeneric
10/2001
1Mesylates (Mesylate)IBA
10/2001
1Hypnotics and Sedatives (Sedatives)IBA
10/2001
1SR 144528IBA
10/2001
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2001
1CB2 Cannabinoid ReceptorIBA
10/2001
1pyrazoleIBA
10/2001
1NicotineFDA Link
10/2001
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2001
1nantradol (levonantradol)IBA
02/2001

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2001